세계의 가축 백신 시장 규모 : 백신 유형별, 대상 동물 종별, 투여 방법별, 최종 사용자별, 지역별 범위와 예측

Farm Animal Vaccine Market Size And Forecast

Farm Animal Vaccine Market size was valued at USD 9.5 USD Billion in 2024 and is projected to reach USD 16.63 USD Billion by 2032, growing at a CAGR of 7.25% during the forecast period 2026-2032.

Global Farm Animal Vaccine Market Drivers

The market drivers for the Farm Animal Vaccine Market can be influenced by various factors. These may include:

Growing Need for Animal Protein: The demand for meat and dairy products rises in tandem with the growth of the world's population. Because of this, there is a greater requirement for healthy farm animals, which raises the need for vaccinations to stave off illnesses that could lower livestock productivity.

Animal illness prevalence: The cattle business can suffer large financial losses as a result of diseases including foot-and-mouth disease, avian influenza, and porcine reproductive and respiratory syndrome (PRRS). The need for vaccines for agricultural animals is fueled by the critical role immunizations play in both preventing and controlling these diseases.

Government Initiatives and laws: To stop the spread of animal diseases, governments and regulatory agencies frequently put programs and laws into place. This includes immunization campaigns, which generate a consistent need for vaccines for farm animals.

Technological developments: Better and safer vaccinations for farm animals have been made possible by developments in biotechnology and vaccine research. These developments stimulate the market's creativity and aid in its expansion.

Increasing Investments in Animal Health: The market for farm animal vaccines is expanding as a result of rising investments in the infrastructure supporting animal healthcare as well as growing awareness of the significance of animal health and welfare.

Trade Globalization: As trade grows, there is a greater chance that diseases will spread internationally. As a result, immunization campaigns are more important to stop the introduction and spread of illnesses to new areas.

Zoonotic diseases are infections that can spread from animals to people and are becoming more common. The need for farm animal vaccines is fueled by the fact that immunizing animals against certain illnesses not only protects them but also lowers the possibility of human infection.

Transition to Preventive Healthcare: Farmers are putting more of an emphasis on preventing illnesses than treating them as a result of a growing tendency in animal husbandry. This promotes vaccination programs' uptake and expands the market for vaccines intended for agricultural animals.

Growing Adoption of Intensive Farming Practices: Because animals are kept in close quarters, intensive farming methods-like concentrated animal feeding operations (CAFOs)-increase the danger of disease outbreaks. Because vaccinations are crucial in stopping the spread of disease in these kinds of settings, there is an increased need for farm animal vaccines.

Global Farm Animal Vaccine Market Restraints

Several factors can act as restraints or challenges for the Farm Animal Vaccine Market. These may include:

Regulatory Difficulties: The lengthy and rigorous regulatory licensing procedures for vaccines might cause delays in the introduction or growth of the market.

High Development expenditures: Research and development expenditures associated with developing vaccines for farm animals might restrict market participants and drive up vaccine pricing.

Limited Knowledge: The growth of the market may be hampered in some areas by farmers who are unaware of the advantages of vaccinations for their animals or who have doubts about their effectiveness.

Infrastructure Challenges: Inadequate infrastructure for the distribution, administration, and storage of vaccines might obstruct market expansion in some areas, particularly in developing nations.

Fragmented Market: Due to the large number of small-scale producers, the market for farm animal vaccines may be fragmented, which could put pressure on prices and restrict innovation.

Disease Control techniques: In certain farming operations, the apparent need for vaccinations may be lessened by effective disease control techniques such the use of antibiotics and biosecurity measures.

Competition from Traditional Medicines: In certain markets, vaccines may face competition from traditional means of illness prevention and treatment, such as antibiotics or herbal medicines.

Economic Factors: Farmers' capacity to spend in vaccines and other preventive measures may be impacted by downturns in the economy or changes in commodity prices.

Concerns regarding Overuse: There may be worries that using vaccines excessively could result in the emergence of disease strains resistant to vaccinations or have a negative impact on the health of animals.

Resistance to Change: Some farmers or farming communities may be resistant to implementing new technologies or practices, such as vaccinations, which could impede the expansion of the market.

Global Farm Animal Vaccine Market Segmentation Analysis

The Global Farm Animal Vaccine Market is Segmented on the basis of Type of Vaccine, Target Animal Species, Administration Method, End-User, and Geography.

Farm Animal Vaccine Market, By Type of Vaccine

• Live Attenuated Vaccines: Vaccines containing weakened forms of the pathogen that stimulate an immune response in animals without causing disease, providing long-lasting immunity with a single dose.
• Inactivated Vaccines: Vaccines containing killed or inactivated pathogens, which require multiple doses or booster shots to induce immunity but are safer for use in pregnant animals and young animals with developing immune systems.
• Subunit Vaccines: Vaccines composed of specific antigens or proteins from the pathogen, offering targeted immune responses with reduced risk of adverse reactions compared to whole-cell vaccines.
• DNA Vaccines: Vaccines that deliver genetic material encoding antigenic proteins into animal cells, stimulating both humoral and cellular immune responses for long-term protection against pathogens.

Farm Animal Vaccine Market, By Target Animal Species

• Cattle: Vaccines developed specifically for cattle to prevent diseases such as bovine respiratory disease (BRD), bovine viral diarrhea (BVD), infectious bovine rhinotracheitis (IBR), and clostridial infections.
• Pigs: Vaccines designed for pigs to protect against diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, porcine circovirus-associated diseases (PCVAD), and classical swine fever.
• Poultry: Vaccines formulated for poultry species including chickens, turkeys, and ducks to prevent diseases such as Newcastle disease, infectious bronchitis, avian influenza, Marek's disease, and infectious bursal disease.
• Sheep and Goats: Vaccines tailored for sheep and goats to control diseases such as foot-and-mouth disease (FMD), enterotoxemia, clostridial infections, and contagious ecthyma (orf).

Farm Animal Vaccine Market, By Administration Method

• Injectable Vaccines: Vaccines administered through injection into muscle tissue or under the skin, providing targeted delivery and reliable immune responses.
• Oral Vaccines: Vaccines administered orally through feed or drinking water, offering ease of administration and potential for mass vaccination of large animal populations.
• Intranasal Vaccines: Vaccines delivered through the nasal passages, stimulating mucosal immunity and providing protection against respiratory pathogens in farm animals.

Farm Animal Vaccine Market, By End-User

• Veterinary Hospitals and Clinics: Facilities providing veterinary services and healthcare to farm animals, including vaccination programs, preventive care, and treatment of infectious diseases.
• Livestock Producers: Farmers, ranchers, and livestock producers responsible for managing the health and well-being of farm animals, including implementing vaccination protocols and disease prevention strategies.
• Veterinary Diagnostic Laboratories: Laboratories conducting diagnostic tests, serological assays, and vaccine efficacy studies to monitor disease prevalence, assess vaccine effectiveness, and guide vaccination strategies.
• Animal Health Companies: Manufacturers and suppliers of farm animal vaccines, veterinary pharmaceuticals, and biological products, offering a range of vaccine formulations and solutions for disease prevention and control.

Farm Animal Vaccine Market, By Geographic

• North America: Market dynamics and trends specific to the farm animal vaccine industry in North American regions, including the United States, Canada, and Mexico.
• Europe: Market factors and regulatory influences shaping the farm animal vaccine market across European countries such as the UK, Germany, France, and Italy.
• Asia Pacific: Growth opportunities and market expansion strategies relevant to farm animal vaccines in countries like China, India, Japan, and Australia.
• Latin America: Market trends and consumer preferences impacting the farm animal vaccine market in Latin American regions like Brazil, Argentina, and Chile.
• Middle East and Africa: Factors driving demand for farm animal vaccines in regions like the Middle East and Africa, including increasing livestock production, disease outbreaks, and government initiatives for animal health.

Key Players

• The major players in the Farm Animal Vaccine Market are:
• Elanco
• Virbac
• Vetoquinol S.A.

4Hester Biosciences Limited

• Phibro Animal Health Corporation
• HIPRA

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FARM ANIMAL VACCINE MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL FARM ANIMAL VACCINE MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL FARM ANIMAL VACCINE MARKET, BY TYPE OF VACCINE

• 5.1 Live Attenuated Vaccines
• 5.2 Inactivated Vaccines
• 5.3 Subunit Vaccines
• 5.4 DNA Vaccines

6 GLOBAL FARM ANIMAL VACCINE MARKET, BY TARGET ANIMAL SPECIES

• 6.1 Cattle
• 6.2 Pigs
• 6.3 Poultry
• 6.4 Sheep and Goats

7 GLOBAL FARM ANIMAL VACCINE MARKET, BY ADMINISTRATION METHOD

• 7.1 Injectable Vaccines
• 7.2 Oral Vaccines
• 7.3 Intranasal Vaccines

8 GLOBAL FARM ANIMAL VACCINE MARKET, BY END-USER

• 8.1 Veterinary Hospitals and Clinics
• 8.2 Livestock Producers
• 8.3 Veterinary Diagnostic Laboratories
• 8.4 Animal Health Companies

9 GLOBAL FARM ANIMAL VACCINE MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
• 92.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East And Africa

10 GLOBAL FARM ANIMAL VACCINE MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Boehringer Ingelheim
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Merck
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Zoetis
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 WINSUN
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Ringpu Biology
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Ceva
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.11 CAHIC
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments
• 11.8 HVRI
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.11 Bio-Labs
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments
• 11.10 Yebio
  • 11.10.1 Overview
  • 11.10.2 Financial Performance
  • 11.10.3 Product Outlook
  • 11.10.4 Key Developments

12 Appendix

• 10.1 Related Research